Application of Benchmark Dose (BMD) in estimating biological exposure limit (BEL) to cadmium

Biomedical and Environmental Sciences

Volumn 20, Issue 6, 2007, Pages 460-464

  Shao, Bo ^a   Jin, Tai Yi ^a   Wu, Xun Wei ^a   Kong, Qing Hu ^b   Ye, Ting Ting ^a  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Benchmark dose; Biological exposure limit; Biomarker

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CADMIUM;

ALBUMINURIA; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; DOSE RESPONSE; FEMALE; HUMAN; MALE; OCCUPATIONAL EXPOSURE; URINE;

ACETYLGLUCOSAMINIDASE; ALBUMINURIA; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CADMIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; SPECTROPHOTOMETRY, ATOMIC;

EID: 38949168407     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Crump K S (1984). A new method for determining allowable daily intakes. Fundam Appl Toxicol 4, 854-871.
2. Gaylor D, Ryan L, Krewski D, et al. (1998). Procedures for calculating benchmark doses for health risk assessment. Regul Toxicol Pharmacol 28, 150-164.
3. Kobayashi E, Suwazono Y, Uetani M, et al. (2006). Estimation of benchmark dose as the threshold levels of urinary cadmium based on excretion of total protein, beta (2)-microglobulin, and N-acetyl-beta-d-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res 101, 401-406.
4. Järup L, Berglund M, Elinder C G, et al. (1998). Health effects of cadmium exposure-A review of the literature and a risk estimate. Scand Work Environ Health 24, 1-51.
5. Buchet J P, Lauwerys R R, Roles H (1990). Renal effects of cadmium body burden of the general population. Lancet 336, 699-702.
6. American Conference of Governmental Industrial Hygienists (2004). Biological exposure indices adopted by ACGIH with intended changes for 2004. USA, ACGIH.
7. The People's Republic of China (1999). Health standard for biological monitoring indices and occupational exposure limit (WS/T113-199). Beijing, (in Chinese)
8. Tucker S M, Boye P J, Thompso A E (1975). Automated assay of N-acetyl-ß-D-glucosaminidase in normal and pathological human urine. Chim Acta 62, 333-339.
9. Hare R S (1950). Endogenous creatinine serum and urine. Proc Soc Exp Biol Med 74, 148-151.
10. Jin T, Nordberg M, Frech W (2002). Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China. Biometals 15, 397-410.
11. Kavlock R J (1997). Recent advances in mathematical modeling of developmental abnormalities using mechanistic information. Reprod Toxicol 11, 423-434.
12. World Health Organization (1992). Environmental Health Criteria 135: Cadmium-Environmental Aspects. Geneva. WHO. 24-35.
13. Kawada T, Koyama H, Suzuki S (1989). Cadmium, NAGactivity and ß2-microgloburin in the urine of cadmium pigment workers. Br J Ind Med 46, 52-55.
14. Jin T, Wu X, Tang Y (2004). Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. Biometals 17, 525-530.